Clinical trials for Combined hepatocellular carcinoma and cholangiocarcinoma
96 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT06902246Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular CarcinomaUniversity of Miami · PI: Lynn G Feun, MD
- RECRUITINGPhase 1NCT07419841A Phase 1 Study of the Safety and Tolerability of CTX-10726Compass Therapeutics · PI: Cynthia Sirard, MD
- RECRUITINGPhase 1NCT07493044An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular CarcinomaGuangzhou FineImmune Biotechnology Co., LTD. · PI: BINKUI LI, Professor
- RECRUITINGPhase 2NCT07122089Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein ThrombosisCenter Eugene Marquis · PI: Etienne Garin, MD PHD
- RECRUITINGPHASE1, PHASE2NCT07482059A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular CarcinomaWest China Hospital
- RECRUITINGPhase 2NCT06254248Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular CarcinomaAssistance Publique - Hôpitaux de Paris
- RECRUITINGN/ANCT07469319Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral CirrhosisUniversity of Aarhus
- RECRUITINGEarly Phase 1NCT07242417TC-G203 for Patients With GPC3-Positive Advanced Solid TumorsBeijing GoBroad Hospital
- RECRUITINGPhase 2NCT07324304NWRD06 DNA Plasmid for HCC After Curative Resection.Newish Technology (Beijing) Co., Ltd.
- RECRUITINGPhase 3NCT07322848DEB-TACE vs cTACE in HCC After TIPSFirst Affiliated Hospital, Sun Yat-Sen University
- RECRUITINGNCT07235410Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACEUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGPhase 3NCT07267806Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCCLinhui Peng
- RECRUITINGPhase 2NCT07192185Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & BevacizumabSun Yat-sen University · PI: Ming Shi
- ACTIVE NOT RECRUITINGPhase 2NCT07138885A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular CarcinomaSun Yat-sen University · PI: Pei-Hong Wu, Professor
- RECRUITINGPhase 3NCT06841172Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCCShandong Cancer Hospital and Institute · PI: Jinbo Yue, Doctor
- RECRUITINGPHASE1, PHASE2NCT06938880Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid TumorsSuzhou Zelgen Biopharmaceuticals Co.,Ltd · PI: Jason Wu
- RECRUITINGNCT06944483Same-day Radioembolization for Large HCCSeoul National University Hospital
- RECRUITINGNCT06544629Imjudo & Imfinzi PMSAstraZeneca
- RECRUITINGNCT06940102Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive TumorsChangchun GeneScience Pharmaceutical Co., Ltd. · PI: Cheng Du
- RECRUITINGPhase 2NCT07246668A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaYonsei University
- ACTIVE NOT RECRUITINGNCT06635694naVIGation Invitations Liver surveillANce upTakeImperial College London
- RECRUITINGNCT07385521The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver MetastasesFrancesco De Cobelli
- ACTIVE NOT RECRUITINGN/ANCT07009470A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for RecurrenceTongji Hospital · PI: Zhiyong Huang
- RECRUITINGNCT06873269Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular CarcinomaUniversitair Ziekenhuis Brussel
- RECRUITINGPhase 1NCT06710223Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and TremelimumabUniversity of California, San Diego · PI: Adam Burgoyne, MD, PhD
- RECRUITINGPHASE1, PHASE2NCT06725121Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before TransplantUniversity Health Network, Toronto · PI: Gonzalo Sapisochin, MD, PhD, MSc
- RECRUITINGN/ANCT06475118Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular CarcinomaCHU de Reims
- ENROLLING BY INVITATIONNCT06624189Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With CirrhosisNYU Langone Health · PI: Saul Blecker
- RECRUITINGN/ANCT06541990Psychoeducational Intervention for Patients With Hepatocellular CarcinomaMassachusetts General Hospital
- RECRUITINGN/ANCT06077591Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid TumorsChinese University of Hong Kong · PI: James Lau
- RECRUITINGPhase 2NCT06742424PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCCWest China Hospital
- RECRUITINGPhase 3NCT05744219Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trialJon Unosson
- RECRUITINGN/ANCT06542796Study on the Classification of Comprehensive Treatment Effect of Hepatocellular CarcinomaSecond Affiliated Hospital, School of Medicine, Zhejiang University
- ACTIVE NOT RECRUITINGPhase 2NCT06524466Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular CarcinomaSun Yat-sen University · PI: Yaojun Zhang
- RECRUITINGPhase 2NCT06363825A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular CarcinomaFujian Medical University · PI: Zhong Tang
- RECRUITINGPhase 2NCT06301399Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety StudyTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT06280313Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal HypertensionZhiyong Huang · PI: Zhiyong Huang
- RECRUITINGNCT06342414An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver CancerCity of Hope Medical Center · PI: Ajay Goel, PhD
- RECRUITINGNCT06261047Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver CancerShandong Cancer Hospital and Institute · PI: jibo yue, dorctor
- ENROLLING BY INVITATIONN/ANCT06061328Project OASIS: Optimizing Approaches to Select Implementation StrategiesVA Office of Research and Development · PI: Shari S Rogal, MD MPH
- RECRUITINGN/ANCT06694636Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular CarcinomaZhongda Hospital · PI: Gao-Jun Gao-Jun
- RECRUITINGNCT05787197ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver MetastasesGERCOR - Multidisciplinary Oncology Cooperative Group · PI: Maximiliano GELLI, MD
- RECRUITINGNCT06179602Prospective Cohort Study on Thermal Ablation of Malignant Liver TumorsLeiden University Medical Center · PI: Mark C. Burgmans, MD PhD
- RECRUITINGPhase 4NCT06084234National Liver Cancer Screening TrialUniversity of Texas Southwestern Medical Center · PI: Amit Singal, MD, MS
- RECRUITINGN/ANCT06190665DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCCZhongda Hospital · PI: Gao-Jun Teng
- RECRUITINGNCT06157060Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNAZhujiang Hospital · PI: Mingxin Pan
- RECRUITINGPhase 2NCT05970666Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular CarcinomaThe First Affiliated Hospital of Xiamen University · PI: Jianbo Chen
- ENROLLING BY INVITATIONNCT05429190Validation of SMS Protocol for HCC Screening in High-risk PatientsErasmus Medical Center · PI: Prof. Dr. de Man
- ACTIVE NOT RECRUITINGN/ANCT07207343Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging.National Taiwan University Hospital
- ACTIVE NOT RECRUITINGPhase 3NCT05904886A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)Hoffmann-La Roche · PI: Clinical Trials
- RECRUITINGN/ANCT0587189218F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular CarcinomaUniversity of Aarhus
- RECRUITINGN/ANCT05994859SIRT for Potentially Resectable HCCSecond Affiliated Hospital of Guangzhou Medical University
- ACTIVE NOT RECRUITINGPhase 2NCT06138769Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular CarcinomaAsan Medical Center · PI: Changhoon Yoo, MD, PhD
- RECRUITINGPhase 2NCT05954429A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 StudyFudan University
- RECRUITINGPhase 2NCT05451043Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)AHS Cancer Control Alberta
- RECRUITINGPhase 2NCT05775159Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerAstraZeneca
- RECRUITINGPhase 2NCT05516628Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular CarcinomaNational Cancer Centre, Singapore · PI: Pierce CHOW, MD, PhD
- RECRUITINGN/ANCT05339984Hepatic and Systemic Hemodynamic Modeling During Liver SurgeryAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT06212635Hemostasis in Liver Cirrhosis and Hepatocellular CancerRegion Stockholm · PI: Maria Magnusson, MD, PhD
- RECRUITINGPhase 1NCT05394259A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerM.D. Anderson Cancer Center · PI: Yang Lu, MD, PHD
- RECRUITINGPHASE1, PHASE2NCT05417932A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular CarcinomaSCG Cell Therapy Pte. Ltd. · PI: SCG Cell Therapeutics
- RECRUITINGNCT06805552Sarcopenia and Systemic Therapy in HCCIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGN/ANCT05443087TARGETed Therapy Drug MONITOring in DIGestive OncologyUNICANCER · PI: David MALKA, Dr
- RECRUITINGPhase 2NCT06404840Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II StudyTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT06777017Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?IRCCS Azienda Ospedaliero-Universitaria di Bologna · PI: Rocco Maurizio Zagari, MD
- RECRUITINGN/ANCT05428735The DRAGON 2 TrialMaastricht University · PI: Ronald M. van Dam, PhD
- RECRUITINGNCT05199259Multi-analyte Blood Test Clinical TrialHelio Genomics · PI: Taggert
- RECRUITINGPhase 1NCT05155189A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular CarcinomaZhejiang University
- RECRUITINGN/ANCT04655885Cardiac Output Optimization on Postoperative Complications in Major Hepatic SurgeryInstitut Paoli-Calmettes · PI: Jean-Manuel de Guibert, MD
- RECRUITINGN/ANCT05186116LDLT in Non Resectable Colo-rectal Cancer Liver MetastasisAzienda Ospedaliero-Universitaria di Modena
- ACTIVE NOT RECRUITINGN/ANCT06682377Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular CarcinomaSeoul National University Hospital
- RECRUITINGN/ANCT04499833HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaCentro Hospitalar de Lisboa Central · PI: Hugo Pinto-Marques, MD PhD
- ACTIVE NOT RECRUITINGPhase 3NCT04712643A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular CarcionmaHoffmann-La Roche · PI: Clinical Trials
- RECRUITINGN/ANCT06627634Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the LiverAarhus University Hospital · PI: Daniel Willy Kjaer, MD, PhD
- RECRUITINGN/ANCT06487663TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant TumorsTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT07186010Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving ImmunotherapyAsan Medical Center · PI: Ju Hyun Shim
- RECRUITINGPhase 2NCT04150744RFA Plus Carrizumab vs Carrizumab Alone for HCCSecond Affiliated Hospital, School of Medicine, Zhejiang University · PI: Zhe Tang, Dr.
- RECRUITINGNCT05713994Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular CarcinomaZe-yang Ding, MD · PI: Wanguang Zhang, M.D.
- ACTIVE NOT RECRUITINGN/ANCT06766773Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver CancerThe First People's Hospital of Neijiang
- RECRUITINGPHASE1, PHASE2NCT03942328Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver CancerMayo Clinic · PI: Lewis R. Roberts, MD, PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06239155A Phase I/II Study of AST-3424 in Subjects With Advanced Solid TumorsAscentawits Pharmaceuticals, Ltd · PI: Jin Li
- RECRUITINGPhase 1NCT04147078Personalized DC Vaccine for Postoperative CancerSichuan University
- RECRUITINGNCT05143619Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis GuidelinesM.D. Anderson Cancer Center · PI: Khaled M Elsayes, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03869034HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCCSun Yat-sen University · PI: Min-shan Chen, MD, PhD
- RECRUITINGNCT06405321Conversion or Neoadjuvant Therapy in Hepatocellular CarcinomaGuangxi Medical University · PI: Jian-Hong Zhong, Ph.D
- ACTIVE NOT RECRUITINGPhase 1NCT02932956Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)Baylor College of Medicine · PI: David Steffin, M.D.
- ACTIVE NOT RECRUITINGNCT03695952A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint InhibitorsAsan Medical Center · PI: Changhoon Yoo, MD
- RECRUITINGN/ANCT03686709Y90 Radioembolization Dose Delivery and Radiation Exposure AssessmentUniversity of Tennessee · PI: Dustin Osborne, PhD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03143270A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver CancerMemorial Sloan Kettering Cancer Center · PI: James Harding, MD
- ACTIVE NOT RECRUITINGPhase 4NCT03024684Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative TreatmentChiayi Christian Hospital · PI: Po Yueh Chen, Doctor
- RECRUITINGN/ANCT02886104Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver MetastasisSixth Affiliated Hospital, Sun Yat-sen University · PI: Meijin Huang, MD,PHD
- ACTIVE NOT RECRUITINGPhase 2NCT02519348A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaMedImmune LLC · PI: MedImmune, LLC MedImmune, LLC
- ACTIVE NOT RECRUITINGPhase 3NCT02523443Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver ResectionMemorial Sloan Kettering Cancer Center · PI: Vittoria Arslan-Carlon, MD
- RECRUITINGNCT07399236AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)Tongji Hospital
- ACTIVE NOT RECRUITINGN/ANCT02156739Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsM.D. Anderson Cancer Center · PI: Janio Szklaruk, MD, PHD
- RECRUITINGNCT01762813Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal CancerHelse Stavanger HF · PI: Kjetil Søreide, MD, PhD, FRCS, FACS